Log in to save to my catalogue

Macrophage activation syndrome in a patient with axial spondyloarthritis on adalimumab

Macrophage activation syndrome in a patient with axial spondyloarthritis on adalimumab

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7087649

Macrophage activation syndrome in a patient with axial spondyloarthritis on adalimumab

About this item

Full title

Macrophage activation syndrome in a patient with axial spondyloarthritis on adalimumab

Publisher

London: Springer London

Journal title

Clinical rheumatology, 2019-02, Vol.38 (2), p.603-608

Language

English

Formats

Publication information

Publisher

London: Springer London

More information

Scope and Contents

Contents

Macrophage activation syndrome (MAS) is a rare and potentially fatal condition characterized by excessive activation and uncontrolled proliferation of T lymphocytes and macrophages, leading to overwhelming systemic inflammation and cytokine release. MAS has been reported with viral infections, autoimmune disorders, malignancies, and medications. We...

Alternative Titles

Full title

Macrophage activation syndrome in a patient with axial spondyloarthritis on adalimumab

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7087649

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7087649

Other Identifiers

ISSN

0770-3198

E-ISSN

1434-9949

DOI

10.1007/s10067-018-4387-5

How to access this item